US Map / Iowa
State IA

Clinical Trials in Iowa

Recruiting clinical trials with at least one study location in Iowa. Data updated daily from ClinicalTrials.gov.

Total Trials
134
Recruiting Now
134
← Back to US Map
Top Conditions in Iowa
Chronic Lymphocytic Leukemia (4)Non-small Cell Lung Cancer (3)Stage IVB Prostate Cancer AJCC v8 (3)Small Lymphocytic Lymphoma (3)COVID-19 (3)Head and Neck Squamous Cell Carcinoma (2)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)Stage II Lip and Oral Cavity Cancer AJCC v8 (2)Multiple Myeloma (2)Crohn's Disease (2)Stage IV Lung Cancer AJCC v8 (2)

Frequently Asked Questions — Clinical Trials in Iowa

How many clinical trials are currently recruiting in Iowa?
ClinicalMetric currently tracks 134 actively recruiting clinical trials with at least one location in Iowa. The total number of registered studies—including active but not currently enrolling trials—is 134. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Iowa?
Iowa hosts clinical trials across a broad range of medical conditions, including Chronic Lymphocytic Leukemia, Non-small Cell Lung Cancer, Stage IVB Prostate Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Iowa serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Iowa?
To join a clinical trial in Iowa, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Iowa maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Iowa

NCT05693025 Phase 1, Phase 2
Recruiting
Evaluation of the Walk With Ease Program for Fall Prevention
Condition
Exercise
Enrollment
240 pts
Location
United States
Sponsor
Iowa State University
View Trial →
NCT07215624 N/A
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Netw...
Condition
Malignant Digestive System Neoplasm
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT05821959 Phase 1, Phase 2
Recruiting
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Condition
Sensorineural Hearing Loss, Bilateral
Enrollment
22 pts
Location
United States, Canada, Taiwan
Sponsor
Akouos, Inc.
View Trial →
NCT06975046 N/A
Recruiting
Aerodynamic Measurements in the Pediatric Population
Condition
Normal Voice
Enrollment
365 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06110897 N/A
Recruiting
RESISTance Exercise for Depression Trial
Condition
Major Depressive Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06395402 Phase 2
Recruiting
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
Condition
Neuroendocrine Tumors
Enrollment
120 pts
Location
United States
Sponsor
University of Iowa
View Trial →
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03295981 Phase 3
Recruiting
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of ...
Condition
Giant Cell Tumor of Bone
Enrollment
120 pts
Location
United States, Canada, India
Sponsor
St. Louis University
View Trial →
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT06547619 EARLY_Phase 1
Recruiting
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunc...
Condition
Gestational Diabetes
Enrollment
40 pts
Location
United States
Sponsor
Anna Stanhewicz, PhD
View Trial →
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
View Trial →
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
View Trial →
NCT06860152 N/A
Recruiting
Cochlear Implant Speech in Noise Processing
Condition
Hearing Loss, Adult-Onset
Enrollment
150 pts
Location
United States
Sponsor
Phillip Gander
View Trial →
NCT05797610 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Partici...
Condition
Primary IgA Nephropathy
Enrollment
428 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT03954899 N/A
Recruiting
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in...
Condition
Mild Cognitive Impairment
Enrollment
230 pts
Location
United States
Sponsor
Natalie Denburg
View Trial →
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
View Trial →
NCT06686771 Phase 3
Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Condition
Non-small Cell Lung Cancer
Enrollment
320 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05243043 N/A
Recruiting
Interactive Resuscitation Application for Mothers About to Experience Premature ...
Condition
Resuscitation
Enrollment
80 pts
Location
United States
Sponsor
Stephanie Stewart
View Trial →
NCT04333537 Phase 2, Phase 3
Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...
Condition
Buccal Mucosa Squamous Cell Carcinoma
Enrollment
686 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT05406622 N/A
Recruiting
MOTIV BTK Randomized Controlled Trial
Condition
Critical Limb Ischemia
Enrollment
292 pts
Location
United States, Germany
Sponsor
REVA Medical, Inc.
View Trial →
NCT06840093 N/A
Recruiting
Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Rand...
Condition
Postoperative Restriction
Enrollment
84 pts
Location
United States
Sponsor
University of Iowa
View Trial →
Page 2 of 6 — 134 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology